Pfizer Ponders Divesting Non-Core Consumer Brands In Europe
This article was originally published in The Rose Sheet
Executive Summary
Pfizer's decision to sell many of its smaller consumer brands in Europe could portend a similar scenario in the U.S. The Morris Plains, N.J.-based firm announced Jan. 13 that it "will explore strategic options for approximately 60 of its non-core consumer products in Europe, including the possible sale of these products.